| As an important branch in the field of biology in the 21 st century,genetic technology will usher in huge development potential.Along with the strong support of national macro policies,as well as the rapid development of Chinese economy and the reform of various medical system systems,it has created a huge development space and a broad platform for the development of the genetic industry.With the encouragement of conservative national policies,the global market size of the gene industry in 2020 is about $18 billion,and the domestic market size is estimated at RMB 24.8 billion.Seeing the prospect of growth in the market size of this field,many companies have flocked to the industry,leading to increasingly severe competition.At the same time,market demand is also moving toward diversification and personalization.In order to adapt to the future direction of the industry,BGI Genetics needs to study sustainable strategies to meet the development needs.BGI Genetics is committed to promoting the process of life sciences and improving the medical health of all human beings,relying on its scientific research results and advanced genetic technologies to be applied in the medical and health fields of people’s livelihood,reducing the rate of birth defects,strengthening the prevention and control of oncological diseases,suppressing major diseases affecting human health,providing accurate screening and auxiliary diagnostic services,and promoting the development of precision medicine.This dissertation is divided into five chapters: Chapter 1 introductory section,which objectively describes the background and significance of the study,research methodology and content,literature review and theoretical foundation;Chapter 2 is based on the current development status of the research object,BGI Genetics,and objectively analyzes the current problems and causes of the company.Chapter 3 focuses on the analysis of the environment in which the company is located,including the macro environment,the overall industry environment and the internal resource environment,etc.The SWOT model is used to analyze the strengths and weaknesses of the company and the opportunities and challenges it faces;Chapter 4 focuses on the selection and formulation of the development strategy objectives of the company,based on the strategic objectives of the company,considering the objective environment in which the company is located,and elaborating the implementation and safeguards of the development strategy of the company.Through an overall study of the development of BGI Genetics,considering its current industry background and combining the strengths and weaknesses of the company’s own development,the company has chosen an enhanced corporate development strategy,including a product development strategy,strengthening product technology research and development innovation,developing new product technologies to meet the diversified and personalized needs of the market;a backward integration strategy,by acquiring the sequencer platform from an upstream supplier,BGI Genetics will master the core technology,achieve independent production,and obtain cost control,while using technological innovation to develop the most promising products and services to meet market demand;diversified development strategy,for different types of disease screening in the medical and health field,the product and service categories required are different.BGI Genetics uses its genetic technology innovation to develop new products and services to meet the needs of emerging markets.Although the subject of this paper is BGI Genetics,the dilemma of its development is a common problem for all companies in the genetic industry.Through a comprehensive analysis of the current development status of BGI Genetics,we hope to explore a sustainable strategic development plan for its future development,which will hopefully provide some reference for other genetic companies in the industry to choose and formulate their development strategies. |
PDF Full Text Request